Skip to main content

E-book

Trends shaping pharma strategy in 2026

How should pharma manufacturers strategically evolve as the industry shifts? Get expert insights from Advisory Board and Optum® Life Sciences.

How to prioritize what matters

Each year, Advisory Board and Optum® Life Sciences experts analyze the trends shaping the future for life sciences organizations. This year’s e-book spotlights 5 critical shifts that require strategic consideration in 2026. These shifts call for a more adaptive, data-informed and stakeholder-aware approach to strategy. 

Related healthcare insights

View all

Article

How real-world evidence can inform pharma strategies in 2025

Health economics and outcomes research (HEOR) can play a key role in helping the life sciences industry improve patient outcomes.

Case study

Identifying patients' bone fracture risk

Optum Life Sciences experts used real-world data to assist in the testing of an algorithm designed to assess for osteoporosis risk.

Article

4 ways small biopharma can harness RWD

Small and emerging biopharma companies are already having an impact on the industry. Learn how RWD can enhance the ability to innovate.